Center for Medicine
Department of Rheumatology and Clinical Immunology &
Center for Chronic Immunodeficiency
Medical Center – University of Freiburg
Hugstetter Str. 55
79106 Freiburg i. Brsg.
- +49 (0) 761/ 270 – 62170
- marta.rizzi@uniklinik-freiburg.de
- Homepage
Current position
Margarete von Wrangell Fellow, Group leader, Department of Rheumatology and Clinical Immunology, Center for Medicine, Medical Center – University of Freiburg
Academic training
| 2007 | Specialization in Allergy and Clinical Immunology, University of Genoa (Italy) |
| 1993 – 1999 | Study of Medicine in Genoa, Italy |
| 2018 | Habilitation in Experimental Medicine, University of Freiburg (Mentor: Prof. Dr. Reinhard Voll) |
| 2000 – 2004 | PhD Thesis in Clinical and Experimental Immunology, University of Genoa and University of California San Diego, USA (Supervisors: Prof. Dr. F. Indiveri – University of Genoa and Prof. Dr. M. Zanetti - UCSD) |
Postgraduate Positions
| since 2014 | Group leader, Department of Rheumatology and Clinical Immunology, Medical Center - University of Freiburg |
| 2011 – 2014 | Postdoctorate, Center for Chronic Immunodeficiency, Medical Center – University of Freiburg |
| 2007 – 2011 | Postdoctorate, Department of Rheumatology, University of Freiburg |
| 2004 – 2007 | Assistant physician in Allergology and Clinical Immunology, University of Genoa, Italy |
| 2000 – 2003 | Research Fellow, Department of Medicine, University of California, San Diego, USA |
Miscellaneous (Honors, Awards)
| 2018 | Mathilde-Wagner Habilitation Prize, Gender Equality Office, Faculty for Medicine, University of Freiburg |
| 2015 | Fellowship of the Elite program for postdocs (Baden-Württemberg Foundation) |
| 2014 – 2018 | Speaker of the B-cell study group of the German Society of Immunology (DGfI) |
| 2014 – 2018 | Margarete von Wrangell Habilitation Fellowship (Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg) |
| 2014 – 2016 | Walter-Hitzig Fellowship (Center for Chronic Immunodeficiency) |
| 2006 – 2007 | DAAD Fellowship |
| 2002 – 2003 | A. P. Giannini Foundation: Postdoctorate Fellowship |
link to all publications from M. Rizzi: Pubmed
Publications based on CRC1160 funding
Susana Minguet, Alexander Nyström, Dimitra Kiritsi, Marta Rizzi. 2022. Inborn errors of immunity and immunodeficiencies: Antibody-mediated pathology and autoimmunity as a consequence of impaired immune reactions. Eur J Immunol, First published: 20 April 2022; doi.org/10.1002/eji.202149529
Oberhardt V, Luxenburger H, Kemming J, Schulien I, Ciminski K, Giese S, Csernalabics B, Lang-Meli J, Janowska I, Staniek J, Wild K, Basho K, Marinescu MS, Fuchs J, Topfstedt F, Janda A, Sogukpinar O, Hilger H, Stete K, Emmerich F, Bengsch B, Waller CF, Rieg S, Sagar, Boettler T, Zoldan K, Kochs G, Schwemmle M, Rizzi M, Thimme R, Neumann-Haefelin C, Hofmann M. 2021. Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine. Nature. 28. doi: 10.1038/s41586-021-03841-4.
Micheau O, Rizzi M, Smulski CR. 2021. Editorial: TNFR Superfamily Oligomerization and Signaling. Front Cell Dev Biol. 9:682472.
Kury, P., J. Staniek, O. Wegehaupt, I. Janowska, M. Eckenweiler, R. Korinthenberg, N. Japaridze, M. Pendziwiat, I. Helbig, E. Verhoeyen, J. Jung, A. C. Garcia de Oteyza, M. Proietti, T. Phirtskhalaishvili, I. Rtskhiladze, P. J. Nielsen, S. Ehl, C. Speckmann, and M. Rizzi. 2021. Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1. J Allergy Clin Immunol. S0091-6749(21)00174-3. doi: 10.1016/j.jaci.2021.01.027.
Kalina, T., R. S. Abraham, Rizzi, and M. van der Burg. 2020. Editorial: Application of Cytometry in Primary Immunodeficiencies. Front Immunol 11: 463.
Troilo, A., C. Wehr, I. Janowska, N. Venhoff, J. Thiel, J. Rawluk, N. Frede, J. Staniek, R. Lorenzetti, M. T. Schleyer, G. W. Herget, L. Konstantinidis, M. Erlacher, M. Proietti, N. Camacho-Ordonez, R. E. Voll, B. Grimbacher, K. Warnatz, U. Salzer, and M. Rizzi. 2020. Nonpermissive bone marrow environment impairs early B-cell development in common variable immunodeficiency. Blood 135: 1452-1457.
Lorenzetti R, Janowska I, Smulski CR, Frede N, Henneberger N, Walter L, Schleyer MT, Hüppe JM, Staniek J, Salzer U, Venhoff A, Troilo A, Voll RE, Venhoff N, Thiel J, Rizzi M. 2019. Abatacept modulates CD80 and CD86 expression and memory formation in human B-cells. J Autoimmun. 101:145-152.
Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S, Warnatz K, Seidl M, Venhoff N, Thiel J, Smulski CR, Rizzi M. 2019. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 10:951.
Rizzi, M., R. Lorenzetti, K. Fischer, J. Staniek, I. Janowska, A. Troilo, V. Strohmeier, M. Erlacher, M. Kunze, B. Bannert, D. Kyburz, E. Voll, N. Venhoff, and J. Thiel. 2017. Impact of tofacitinib treatment on human B-cells in vitro and in vivo. J Autoimmun 77: 55-66.
Janda A, Schwarz K, van der Burg M, Vach W, Ijspeert H, Lorenz MR, Elgizouli M, Pieper K, Fisch P, Hagel J, Lorenzetti R, Seidl M, Roesler J, Hauck F, Traggiai E, Speckmann C, Rensing-Ehl A, Ehl S, Eibel H, Rizzi M. 2016. Disturbed B-lymphocyte selection in autoimmune lymphoproliferative syndrome. Blood 127:2193-2202.
